Because PTEN regulated p21 expression via MDM2‐p53 signaling and USP22 induced the deubiquitination of PTEN in pancreatic cancer, we suspected that USP22 could also induce the MDM2‐p53 signaling pathway via PTEN in pancreatic cancer. The gene discussed is MDM2; the disease is familial pancreatic carcinoma.